Divi's Lab posts 17% rise in Q3 net profit to Rs 358 crore
The company’s total revenue for the third quarter was 8.6 per cent higher at Rs 1,855 crore compared to the same period last year.
Stay updated with breaking news from Devendra Rao. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company’s total revenue for the third quarter was 8.6 per cent higher at Rs 1,855 crore compared to the same period last year.
Revenue from operations in the reporting period increased 9% year-on-year to Rs 1,855 crore, compared with Rs 1708 crore in the corresponding period of last year.
Operational performance was on the weaker side as the company's earnings before interest, taxes, depreciation and amortization (EBITDA) came in at Rs 479 crore, up around 19.6 percent from Rs 409 crore.
Pharma major Divi's Laboratories on Saturday reported a 17 per cent increase in its consolidated net profit to Rs 358 crore for the October-December quarter of the current financial year compared to the corresponding figure of Rs 306 crore in ...